Echo Pharmaceuticals ("Echo") announces that Namisol ® has completed successfully a Phase II trial with 24 patients suffering from spasticity and pain due to multiple sclerosis (MS). The trial has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results